Amendment Statement of Principles
concerning
ISCHAEMIC HEART DISEASE
(Balance of Probabilities)
(No. 98 of 2021)
The Repatriation Medical Authority determines the following Amendment Statement of Principles under subsections 196B(3) and (8) of the Veterans' Entitlements Act 1986.
Dated 20 August 2021
The Common Seal of the
|
Professor Terence Campbell AM Chairperson
|
Contents
2 Commencement
3 Authority
4 Amendment
1 Name
This is the Amendment Statement of Principles concerning ischaemic heart disease (Balance of Probabilities) (No. 98 of 2021).
This instrument commences on 20 September 2021.
This instrument is made under subsections 196B(3) and (8) of the Veterans' Entitlements Act 1986.
The Statement of Principles concerning ischaemic heart disease (Balance of Probabilities) (No. 2 of 2016) (Federal Register of Legislation No. F2016L00003) is amended in the following manner:
Section | Amendment |
9(32) | Replace the existing factor in subsection 9(32) with the following: having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical onset of ischaemic heart disease; Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary. |
9(65) | Replace the existing factor in subsection 9(32) with the following: having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical worsening of ischaemic heart disease; Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary. |
Schedule 1 – Dictionary | Delete the existing definition of "specified autoimmune collagen vascular disease". |
Schedule 1 – Dictionary | Insert the following definition of "specified list of autoimmune diseases" in alphabetical order: specified list of autoimmune diseases means: (a) ankylosing spondylitis; (b) Behcet disease; (c) dermatomyositis; (d) eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome); (e) giant cell (temporal) arteritis; (f) IgA vasculitis (Henoch-Schönlein purpura); (g) microscopic polyangiitis; (h) mucocutaneous lymph node syndrome (Kawasaki disease); (i) non-specific autoimmune vasculitis; (j) polyarteritis nodosa; (k) polymyositis; (l) psoriasis; (m) psoriatic arthritis; (n) rheumatoid arthritis; (o) Sjögren syndrome; (p) systemic lupus erythematosus; (q) systemic sclerosis; (r) Takayasu arteritis; (s) thromboangiitis obliterans (Buerger disease); or (t) granulomatosis with polyangiitis (Wegener granulomatosis). |